No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study.
Auteurs : Burlacu R, London J, Fleury A, Sené T, Diallo A, Meyssonnier V, Zeller V, Galland J, Huscenot T, Rubenstein E, Trouiller P, Amathieu R, Kutter J, Blondeel D, Lejour G, Mouly S, Lidove O, Wladimir M, Sène D.
